Characterisation of circulating biomarkers before and after cardiac resynchronisation therapy and their role in predicting CRT response: the COVERT-HF study

AIMS: Cardiac resynchronisation therapy (CRT) is effective treatment for selected patients with heart failure (HF) but has ~30% non-response rate. We evaluated whether specific biomarkers can predict outcome. METHODS: A prospective single-centre pilot study of consecutive unselected patients undergo...

Descripción completa

Detalles Bibliográficos
Autores principales: McAloon, Christopher J, Barwari, Temo, Hu, Jimiao, Hamborg, Thomas, Nevill, Alan, Hyndman, Samantha, Ansell, Valerie, Musa, Anntoniette, Jones, Julie, Goodby, Julie, Banerjee, Prithwish, O’Hare, Paul, Mayr, Manuel, Randeva, Harpal, Osman, Faizel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Heart Failure and Cardiomyopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196945/
https://www.ncbi.nlm.nih.gov/pubmed/30364565
http://dx.doi.org/10.1136/openhrt-2018-000899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196945/
https://www.ncbi.nlm.nih.gov/pubmed/30364565
http://dx.doi.org/10.1136/openhrt-2018-000899

Ejemplares similares